VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 404 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2016. The put-call ratio across all filers is 0.94 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $183,000 | -57.2% | 12,669 | -50.6% | 0.01% | -58.3% |
| Q2 2017 | $428,000 | +205.7% | 25,633 | +74.9% | 0.01% | +200.0% |
| Q1 2017 | $140,000 | -22.2% | 14,655 | +24.6% | 0.00% | -33.3% |
| Q4 2016 | $180,000 | -20.7% | 11,765 | +23.2% | 0.01% | -33.3% |
| Q3 2016 | $227,000 | -3.0% | 9,552 | -6.2% | 0.01% | 0.0% |
| Q2 2016 | $234,000 | +15.3% | 10,188 | +410.9% | 0.01% | -10.0% |
| Q4 2015 | $203,000 | -46.3% | 1,994 | -5.9% | 0.01% | -52.4% |
| Q3 2015 | $378,000 | +58.2% | 2,118 | +27.0% | 0.02% | +40.0% |
| Q4 2014 | $239,000 | 0.0% | 1,668 | -8.6% | 0.02% | -11.8% |
| Q3 2014 | $239,000 | -48.9% | 1,824 | -48.6% | 0.02% | -65.3% |
| Q1 2014 | $468,000 | – | 3,549 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Capital Analysts, LLC | 7,350 | $439,309,000 | 0.18% |
| GOLDMAN SACHS GROUP INC | 2,996,127 | $179,078,000 | 0.07% |
| MUFG Americas Holdings Corp | 52,285 | $3,125,000 | 0.06% |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 22,936 | $1,367,000 | 0.05% |
| GOLDMAN SACHS GROUP INC | 419,100 | $25,050,000 | 0.01% |
| AQR Capital Management | 35,829 | $2,141,000 | 0.01% |
| HSBC HOLDINGS PLC | 33,669 | $2,009,000 | 0.01% |
| GOLDMAN SACHS GROUP INC | 147,000 | $8,786,000 | 0.00% |
| NOMURA HOLDINGS INC | 6,000 | $359,000 | 0.00% |
| Twin Tree Management, LP | 455 | $27,000 | 0.00% |